Cargando…
Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis
Cytokines, demyelination and neuroaxonal degeneration in the central nervous system are pivotal elements implicated in the pathogenesis of multiple sclerosis (MS) and its nonclinical model of experimental autoimmune encephalomyelitis (EAE). Phycocyanobilin (PCB), a chromophore of the biliprotein C-P...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669316/ https://www.ncbi.nlm.nih.gov/pubmed/36405721 http://dx.doi.org/10.3389/fimmu.2022.1036200 |
_version_ | 1784832071509737472 |
---|---|
author | Marín-Prida, Javier Pavón-Fuentes, Nancy Lagumersindez-Denis, Nielsen Camacho-Rodríguez, Hanlet García-Soca, Ana Margarita Sarduy-Chávez, Rocío de la Caridad Vieira, Érica Leandro Marciano Carvalho-Tavares, Juliana Falcón-Cama, Viviana Fernández-Massó, Julio Raúl Hernández-González, Ignacio Martínez-Donato, Gillian Guillén-Nieto, Gerardo Pentón-Arias, Eduardo Teixeira, Mauro Martins Pentón-Rol, Giselle |
author_facet | Marín-Prida, Javier Pavón-Fuentes, Nancy Lagumersindez-Denis, Nielsen Camacho-Rodríguez, Hanlet García-Soca, Ana Margarita Sarduy-Chávez, Rocío de la Caridad Vieira, Érica Leandro Marciano Carvalho-Tavares, Juliana Falcón-Cama, Viviana Fernández-Massó, Julio Raúl Hernández-González, Ignacio Martínez-Donato, Gillian Guillén-Nieto, Gerardo Pentón-Arias, Eduardo Teixeira, Mauro Martins Pentón-Rol, Giselle |
author_sort | Marín-Prida, Javier |
collection | PubMed |
description | Cytokines, demyelination and neuroaxonal degeneration in the central nervous system are pivotal elements implicated in the pathogenesis of multiple sclerosis (MS) and its nonclinical model of experimental autoimmune encephalomyelitis (EAE). Phycocyanobilin (PCB), a chromophore of the biliprotein C-Phycocyanin (C-PC) from Spirulina platensis, has antioxidant, immunoregulatory and anti-inflammatory effects in this disease, and it could complement the effect of other Disease Modifying Treatments (DMT), such as Interferon-β (IFN-β). Here, our main goal was to evaluate the potential PCB benefits and its mechanisms of action to counteract the chronic EAE in mice. MOG(35-55)-induced EAE was implemented in C57BL/6 female mice. Clinical signs, pro-inflammatory cytokines levels by ELISA, qPCR in the brain and immunohistochemistry using precursor/mature oligodendrocytes cells antibodies in the spinal cord, were assessed. PCB enhanced the neurological condition, and waned the brain concentrations of IL-17A and IL-6, pro-inflammatory cytokines, in a dose-dependent manner. A down- or up-regulating activity of PCB at 1 mg/kg was identified in the brain on three (LINGO1, NOTCH1, and TNF-α), and five genes (MAL, CXCL12, MOG, OLIG1, and NKX2-2), respectively. Interestingly, a reduction of demyelination, active microglia/macrophages density, and axonal damage was detected along with an increase in oligodendrocyte precursor cells and mature oligodendrocytes, when assessed the spinal cords of EAE mice that took up PCB. The studies in vitro in rodent encephalitogenic T cells and in vivo in the EAE mouse model with the PCB/IFN-β combination, showed an enhanced positive effect of this combined therapy. Overall, these results demonstrate the anti-inflammatory activity and the protective properties of PCB on the myelin and support its use with IFN-β as an improved DMT combination for MS. |
format | Online Article Text |
id | pubmed-9669316 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-96693162022-11-18 Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis Marín-Prida, Javier Pavón-Fuentes, Nancy Lagumersindez-Denis, Nielsen Camacho-Rodríguez, Hanlet García-Soca, Ana Margarita Sarduy-Chávez, Rocío de la Caridad Vieira, Érica Leandro Marciano Carvalho-Tavares, Juliana Falcón-Cama, Viviana Fernández-Massó, Julio Raúl Hernández-González, Ignacio Martínez-Donato, Gillian Guillén-Nieto, Gerardo Pentón-Arias, Eduardo Teixeira, Mauro Martins Pentón-Rol, Giselle Front Immunol Immunology Cytokines, demyelination and neuroaxonal degeneration in the central nervous system are pivotal elements implicated in the pathogenesis of multiple sclerosis (MS) and its nonclinical model of experimental autoimmune encephalomyelitis (EAE). Phycocyanobilin (PCB), a chromophore of the biliprotein C-Phycocyanin (C-PC) from Spirulina platensis, has antioxidant, immunoregulatory and anti-inflammatory effects in this disease, and it could complement the effect of other Disease Modifying Treatments (DMT), such as Interferon-β (IFN-β). Here, our main goal was to evaluate the potential PCB benefits and its mechanisms of action to counteract the chronic EAE in mice. MOG(35-55)-induced EAE was implemented in C57BL/6 female mice. Clinical signs, pro-inflammatory cytokines levels by ELISA, qPCR in the brain and immunohistochemistry using precursor/mature oligodendrocytes cells antibodies in the spinal cord, were assessed. PCB enhanced the neurological condition, and waned the brain concentrations of IL-17A and IL-6, pro-inflammatory cytokines, in a dose-dependent manner. A down- or up-regulating activity of PCB at 1 mg/kg was identified in the brain on three (LINGO1, NOTCH1, and TNF-α), and five genes (MAL, CXCL12, MOG, OLIG1, and NKX2-2), respectively. Interestingly, a reduction of demyelination, active microglia/macrophages density, and axonal damage was detected along with an increase in oligodendrocyte precursor cells and mature oligodendrocytes, when assessed the spinal cords of EAE mice that took up PCB. The studies in vitro in rodent encephalitogenic T cells and in vivo in the EAE mouse model with the PCB/IFN-β combination, showed an enhanced positive effect of this combined therapy. Overall, these results demonstrate the anti-inflammatory activity and the protective properties of PCB on the myelin and support its use with IFN-β as an improved DMT combination for MS. Frontiers Media S.A. 2022-11-03 /pmc/articles/PMC9669316/ /pubmed/36405721 http://dx.doi.org/10.3389/fimmu.2022.1036200 Text en Copyright © 2022 Marín-Prida, Pavón-Fuentes, Lagumersindez-Denis, Camacho-Rodríguez, García-Soca, Sarduy-Chávez, Vieira, Carvalho-Tavares, Falcón-Cama, Fernández-Massó, Hernández-González, Martínez-Donato, Guillén-Nieto, Pentón-Arias, Teixeira and Pentón-Rol https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Marín-Prida, Javier Pavón-Fuentes, Nancy Lagumersindez-Denis, Nielsen Camacho-Rodríguez, Hanlet García-Soca, Ana Margarita Sarduy-Chávez, Rocío de la Caridad Vieira, Érica Leandro Marciano Carvalho-Tavares, Juliana Falcón-Cama, Viviana Fernández-Massó, Julio Raúl Hernández-González, Ignacio Martínez-Donato, Gillian Guillén-Nieto, Gerardo Pentón-Arias, Eduardo Teixeira, Mauro Martins Pentón-Rol, Giselle Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis |
title | Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis |
title_full | Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis |
title_fullStr | Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis |
title_full_unstemmed | Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis |
title_short | Anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: A therapeutic promise for multiple sclerosis |
title_sort | anti-inflammatory mechanisms and pharmacological actions of phycocyanobilin in a mouse model of experimental autoimmune encephalomyelitis: a therapeutic promise for multiple sclerosis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669316/ https://www.ncbi.nlm.nih.gov/pubmed/36405721 http://dx.doi.org/10.3389/fimmu.2022.1036200 |
work_keys_str_mv | AT marinpridajavier antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT pavonfuentesnancy antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT lagumersindezdenisnielsen antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT camachorodriguezhanlet antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT garciasocaanamargarita antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT sarduychavezrociodelacaridad antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT vieiraericaleandromarciano antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT carvalhotavaresjuliana antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT falconcamaviviana antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT fernandezmassojulioraul antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT hernandezgonzalezignacio antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT martinezdonatogillian antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT guillennietogerardo antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT pentonariaseduardo antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT teixeiramauromartins antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis AT pentonrolgiselle antiinflammatorymechanismsandpharmacologicalactionsofphycocyanobilininamousemodelofexperimentalautoimmuneencephalomyelitisatherapeuticpromiseformultiplesclerosis |